Advancing of cellular signaling pathways in respiratory diseases using nanocarrier based drug delivery systems
Cell Signaling pathways form an integral part of our existence that allows the cells to
comprehend a stimulus and respond back. Such reactions to external cues from the …
comprehend a stimulus and respond back. Such reactions to external cues from the …
Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis
LÁ Ibarra-Sánchez, A Gámez-Méndez… - Journal of Drug Delivery …, 2022 - Elsevier
Respiratory diseases are leading causes of death and disability in developing and
developed countries. The burden of acute and chronic respiratory diseases has been rising …
developed countries. The burden of acute and chronic respiratory diseases has been rising …
Nanocarriers for respiratory diseases treatment: recent advances and current challenges
A Trapani, S Di Gioia, S Castellani… - Current Topics in …, 2014 - ingentaconnect.com
Pulmonary delivery of locally-acting drugs encapsulated in nanocarriers provides several
advantages for the treatment of respiratory diseases such as asthma, chronic obstructive …
advantages for the treatment of respiratory diseases such as asthma, chronic obstructive …
Application of nanotechnology in drug delivery systems for respiratory diseases
MX Luo, S Hua, QY Shang - Molecular Medicine …, 2021 - spandidos-publications.com
Respiratory disease is a common disease with a high incidence worldwide, which is a
serious threat to human health, and is considered a societal and economic burden. The …
serious threat to human health, and is considered a societal and economic burden. The …
[HTML][HTML] Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations–A review
M Kumar, AR Hilles, SHA Almurisi, A Bhatia… - JCIS Open, 2023 - Elsevier
The lung is an attractive target for drug delivery because of the ease of non-invasive
administration via inhalation, bypassing metabolism in the liver, direct delivery to the …
administration via inhalation, bypassing metabolism in the liver, direct delivery to the …
Nanotechnology: Advancing the translational respiratory research
Considering the various limitations associated with the conventional dosage forms,
nanotechnology is gaining increased attention in drug delivery particularly in respiratory …
nanotechnology is gaining increased attention in drug delivery particularly in respiratory …
A comprehensive review of current perspectives on novel drug Delivery systems and approaches for lung cancer management
Cancer is one of the fatal diseases that cause many deaths around the world. Lung cancer
has the highest incidence and mortality rates among cancer-related death worldwide. Lung …
has the highest incidence and mortality rates among cancer-related death worldwide. Lung …
Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases
S Pramanik, S Mohanto, R Manne… - Molecular …, 2021 - ACS Publications
Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …
Special focus issue on targeted drug delivery for inflammatory lung diseases
There are reportedly over five million annual deaths worldwide due to lung-related diseases.
A majority of these subjects suffer from asthma and chronic obstructive pulmonary diseases …
A majority of these subjects suffer from asthma and chronic obstructive pulmonary diseases …
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy
The lack of effective treatments for pulmonary diseases presents a significant global health
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …